NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE233332 Query DataSets for GSE233332
Status Public on May 20, 2024
Title Risk assessment of parabens in a transcriptomics-based in vitro system
Organism Homo sapiens
Experiment type Expression profiling by array
Summary Parabens have been used for decades as preservatives in food, drugs and cosmetics. The majority however, were banned in 2009 and 2014 leaving only methyl-, ethyl-, propyl-, and butyl-derivates available for subsequent use. Methyl- and propylparaben have been extensively tested in vivo, with no resulting evidence for developmental and reproductive toxicity (DART). In contrast, ethylparaben has not yet been tested for DART in animal experiments, and it is currently debated if additional animal studies are warranted. In order to perform a comparison of the four currently-approved parabens, we used a previously established in vitro test based on human induced pluripotent stem cells (iPSC) that are exposed to test substances during their differentiation to neuroectodermal cells. EC50 values for cytotoxicity were 906 µM, 698 µM, 216 µM and 63 µM for methyl-, ethyl-, propyl- and butylparaben, respectively, demonstrating that cytotoxicity increases with increasing alkyl chain length. Genome-wide analysis demonstrated that FDR-adjusted significant gene expression changes occurred only at cytotoxic or close to cytotoxic concentrations, for example 1,720 differentially expressed genes (DEG) at 1,000 µM ethylparaben, 1 DEG at 316 µM, and no DEG at 100 µM or lower concentrations. The highest concentration of ethylparaben that did not induce any cytotoxicity nor DEG was 1670-fold above the highest published concentrations reported in biomonitoring studies (60 nM ethylparaben in cord blood). In conclusion, cytotoxicity and gene expression alterations of ethylparaben occurred at concentrations of approximately three orders of magnitude above human blood concentrations; moreover, the substance fitted well into a scenario where toxicity increases with the alkyl chain length, and gene expression changes only occur at cytotoxic or close to cytotoxic concentrations. Therefore, no evidence was obtained suggesting that in vivo DART with ethylparaben would lead to different results as the methyl- or propyl derivates.
 
Overall design Human iPSCs were differentiated for 6 days according to a neuroepithelial protocol (UKN1) and incubated with parabens at the same time. Cytotoxicity was measured by a CellTiter-Blue® Cell Viability Assay. RNA was isolated from the cells and a whole transcritpome analysis was performed with Affymetrix HG-U133 Plus 2.0 arrays and Illumina RNA sequencing. Paraben-induced gene expression changes were determined and analyzed with statistical models.
 
Contributor(s) Seidel F, Kappenberg F, Fayyaz S, Scholtz-Illigens A, Cherianidou A, Derksen K, Nell P, Marchan R, Edlund K, Leist M, Sachinidis A, Rahnenführer J, Kreiling R, Hengstler JG
Citation missing Has this study been published? Please login to update or notify GEO.
Submission date May 24, 2023
Last update date May 20, 2024
Contact name Jan Georg Hengstler
E-mail(s) hengstler@ifado.de
Organization name Leibniz-Institut für Arbeitsforschung an der TU Dortmund
Department Toxikologie / Systemtoxikologie
Street address Ardeystraße 67
City Dortmund
ZIP/Postal code 44139
Country Germany
 
Platforms (1)
GPL570 [HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array
Samples (97)
GSM7425653 UKN1_SBAD2_Butylparaben_0.316_1
GSM7425654 UKN1_SBAD2_Butylparaben_0.316_2
GSM7425655 UKN1_SBAD2_Butylparaben_0.316_3
Relations
BioProject PRJNA975950

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE233332_RAW.tar 457.6 Mb (http)(custom) TAR (of CEL)
Processed data included within Sample table

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap